Matrixx Initiatives Competitors and Similar CompaniesClear all
Matrixx Initiatives's competitors and similar companies include UCB, Cipla, Livzon Pharmaceutical Group and Biogen.
 Matrixx Initiatives Matrixx Initiatives is a consumer healthcare company engaged in the development of over-the-counter healthcare products. |  UCB UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions. |  Cipla Cipla is a pharmaceutical company focused on the development, manufacturing, and distribution of medications and healthcare products. |  Livzon Pharmaceutical Group Livzon Pharmaceutical Group (丽珠医药集团股份有限公司, 丽珠医药) is a pharmaceutical company that engages in the development and production of active pharmaceutical ingredients, biological drugs, diagnostic reagents, and other products. |  Biogen Biogen (formerly known as Biogen Idec) is a biopharmaceutical company that develops and delivers therapies for neurological and neurodegenerative diseases. | |
Founding Date | Founding Date 1991 | Founding Date 1928 | Founding Date 1935 | Founding Date 1985 | Founding Date 1978 |
Type | Type Subsidiary | Type Public | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations Bridgewater Township, US HQ | Locations Brussels, BE HQ Melbourne, AU Vienna, AT Braine L'alleud, BE Braine L'alleud, BE Leuven, BE São Paulo, BR see more | Locations Mumbai, IN HQ Melbourne, AU Antwerpen, BE São Paulo, BR São Paulo, BR Unterhaching, DE Nairobi, KE see more | Locations Zhuhai, CN HQ Chengdu, CN Qingyuan, CN Shanghai, CN Shaoguan, CN Shenzhen, CN Zhuhai, CN | Locations Cambridge, US HQ Vicente López, AR Macquarie Park, AU Wien, AT Machelen, BE São Paul, BR Toronto, CA see more |
Employees | Employees 6 | Employees 9,052 | Employees 27,764 | Employees 9,067 | Employees 7,605 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 34.3 b | Valuation ($) N/A | Valuation ($) 4.2 b | Valuation ($) 26.7 b |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) €7.4b (FY, 2025) | Revenue (est.) ₹277.1b (FY, 2026) | Revenue (est.) ¥11.7b (FY, 2025) | Revenue (est.) $9.9b (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods €1.4b (FY, 2025) | Cost of goods ₹95.5b (FY, 2026) | Cost of goods ¥4.1b (FY, 2025) | Cost of goods $2.4b (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit €7.2b (FY, 2025) | Gross profit ₹195b (FY, 2026) | Gross profit ¥7.8b (FY, 2025) | Gross profit $7.5b (FY, 2025) |
Net income | Net income N/A | Net income €1.6b (FY, 2025) | Net income ₹38.7b (FY, 2026) | Net income ¥2.4b (FY, 2025) | Net income $1.3b (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
UCB
HQ
Brussels, BE
Employees
9,052
UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions.
View companyCipla
HQ
Mumbai, IN
Employees
27,764
Cipla is a pharmaceutical company focused on the development, manufacturing, and distribution of medications and healthcare products.
View companyLivzon Pharmaceutical Group
HQ
Zhuhai, CN
Employees
9,067
Livzon Pharmaceutical Group (丽珠医药集团股份有限公司, 丽珠医药) is a pharmaceutical company that engages in the development and production of active pharmaceutical ingredients, biological drugs, diagnostic reagents, and other products.
View companyBiogen
HQ
Cambridge, US
Employees
7,605
Biogen (formerly known as Biogen Idec) is a biopharmaceutical company that develops and delivers therapies for neurological and neurodegenerative diseases.
View company